#374: Updated Status of Multiregional Clinical Trials Based on ICH E17 Guideline: 5 Years After the Implementation
Wednesday, June 19, 2024 4:30 PM to 5:30 PM · 1 hr. (US/Pacific)
Room 5AB
02: ClinTrials -ClinOps09: Regulatory
Information
The forum will consist of regulators and industry experts who were the authors of the ICH E17 guidelines. As regulators and sponsors, they will provide first-hand narrative on their experiences in implementing the ICH E17 guidelines.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
ICH
Speakers
YW
Yangfeng Wu
Executive DirectorPeking University Clinical Research Institute
Yoshiaki Uyama
Associate Executive DirectorPharmaceuticals and Medical Devices Agency (PMDA)RS
Romi Singh
Founder & Principal AdvisorGRA AdvisorsDP
Douglas Pratt
Supervisory Medical Officer, OVRR, CBERFDAIL
I-Chun Lai
Senior Director, Division of ConsultationCenter for Drug Evaluation, Taiwan
Yoko Aoi
Coordination Director - Office of Review ManagementPharmaceuticals and Medical Devices Agency (PMDA)
